Transurethral Resection of Non-muscle-invasive Bladder Cancer

被引:38
|
作者
Babjuk, Marko [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Gen Teaching Hosp, Dept Urol, Prague 12808 2, Czech Republic
关键词
Bladder cancer; Bladder tumours; Fluorescence cystoscopy; Narrow-band imaging; Non-muscle-invasive bladder cancer; Random biopsies; Recurrences; Re-TUR; TURB; Understaging; TRANSITIONAL-CELL-CARCINOMA; HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY; WHITE-LIGHT CYSTOSCOPY; IMMEDIATE POSTOPERATIVE INSTILLATION; UROTHELIAL CARCINOMA; PHASE-III; IN-SITU; TUMORS; RECURRENCE; RISK;
D O I
10.1016/j.eursup.2009.06.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Transurethral resection of the bladder (TURB) is the initial and critical step in the management of bladder tumours. The aim of the procedure is to establish the histologic diagnosis, determine the tumour stage and grade, and achieve complete removal of papillary non-muscle-invasive tumours. Although TURB is a frequently performed procedure, its results are limited by the high recurrence rate and by the risk of tumour understaging. The major prerequisite for optimal outcomes is a systematically and meticulously performed procedure by a well-trained urologist. Smaller tumours can be resected en bloc; tumours > 1 cm should be resected separately in fractions. Deep resection, including the detrusor muscle, is essential for correct staging, The biopsy should be taken from all areas suggestive of carcinoma in situ (CIS), and biopsies from normal-looking mucosa are recommended only in patients with positive cytology or non-papillary tumours. TURB should be performed with modern equipment, including new telescopes and video systems. Moreover, urologists should be aware of promising innovations, including new imaging techniques, and their possible benefits. Re-TUR can improve recurrence-free survival (RFS) and tumour staging. It is recommended in any patient with a T1 or high-grade tumour at initial resection and when the pathologist has reported that the specimen contained no muscle. It should also be considered in cases where the urologist is not sure that the initial resection was complete, especially in extensive and multiple tumours. (C) European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:542 / 548
页数:7
相关论文
共 50 条
  • [1] Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series
    Gendy, Rasha
    Delprado, Warick
    Brenner, Phillip
    Brooks, Andrew
    Coombes, Graham
    Cozzi, Paul
    Nash, Peter
    Patel, Manish I.
    [J]. BJU INTERNATIONAL, 2016, 117 : 54 - 59
  • [2] Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review
    Cumberbatch, Marcus G. K.
    Foerster, Beat
    Catto, James W. F.
    Kamat, Ashish M.
    Kassouf, Wassim
    Jubber, Ibrahim
    Shariat, Shahrokh F.
    Sylvester, Richard J.
    Gontero, Paolo
    [J]. EUROPEAN UROLOGY, 2018, 73 (06) : 925 - 933
  • [3] Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer
    Kramer, Mario W.
    Abdelkawi, Islam F.
    Wolters, Mathias
    Bach, Thorsten
    Gross, Andreas J.
    Nagele, Udo
    Conort, Pierre
    Merseburger, Axel S.
    Kuczyk, Markus A.
    Herrmann, Thomas R. W.
    [J]. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2014, 23 (3-4) : 206 - 213
  • [4] Repeat transurethral resection for non-muscle-invasive bladder cancer: how are we going?
    Gendy, R.
    Delprado, W.
    Bariol, S.
    Brooks, A.
    Drummond, M.
    Lau, H.
    Wang, A.
    Patel, M.
    [J]. BJU INTERNATIONAL, 2013, 111 : 116 - 117
  • [5] Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer
    Akitake, Masakazu
    Yamaguchi, Akito
    Shiota, Masaki
    Imada, Kenjiro
    Tatsugami, Katsunori
    Yokomizo, Akira
    Naito, Seiji
    Eto, Masatoshi
    [J]. ANTICANCER RESEARCH, 2019, 39 (08) : 4325 - 4328
  • [6] Comparison of Thulium Laser Resection of Bladder Tumors and Conventional Transurethral Resection of Bladder Tumors for Non-Muscle-Invasive Bladder Cancer
    Liu, Zheng
    Zhang, Yucong
    Sun, Guoliang
    Ouyang, Wei
    Wang, Shen
    Xu, Hao
    Hu, Henglong
    Li, Fan
    Yang, Jun
    Wang, Zhihua
    Guan, Wei
    Yu, Xiao
    Hu, Zhiquan
    Chen, Zhong
    Wang, Shaogang
    Long, Gongwei
    Li, Heng
    [J]. UROLOGIA INTERNATIONALIS, 2022, 106 (02) : 116 - 121
  • [7] Impact of repeat transurethral resection on treatment results in patients with non-muscle-invasive bladder cancer
    Khalmurzayer, O. A.
    Marco, V. B.
    Figurin, R. M.
    Romano, V. A.
    Panakhor, A. D.
    Khafizor, K. O.
    [J]. ONKOUROLOGIYA, 2012, 8 (04): : 33 - 39
  • [8] Impact of secondary transurethral resection on recurrence rates in patients with non-muscle-invasive bladder cancer
    Khalmurzaev, O. A.
    Matveev, V. B.
    Peterson, S. B.
    Romanov, V. A.
    Panakhov, A. D.
    Khailenko, A. V.
    [J]. ONKOUROLOGIYA, 2012, 8 (02): : 66 - 71
  • [9] Update on early instillation of chemotherapy after transurethral resection of non-muscle-invasive bladder cancer
    Oosterlinck, Willem
    Decaestecker, Karel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 437 - 443
  • [10] Re: Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2020, 203 (04): : 661 - 661